EFMC-ISMC 2012, recognized worldwide as one of the leading Medicinal Chemistry meetings, is expected to attract about 1200–1400 participants from around the world. Its highly targeted audience is composed by experts in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, early toxicology, as well as chemical and pharmaceutical development.

For companies active in the field of Medicinal Chemistry the Symposium represents an excellent opportunity to promote the quality of their scientific activities and to confirm their support to the discipline itself.

Need some more facts on ISMC Symposia?

At ISMC 2010 in Brussels a total of 45 exhibitors were present and - most importantly for you, as an exhibitor - the participants, 49% of which were from Industry, were representing over 40 countries world-wide. Out of the Industry affiliated participants, 37% of them were on a decision-making level and 22% had a top management position; while 50% of them were representatives of one of the Top 50 Pharma Companies and 34% were from Biotech Companies and other smaller Pharma companies.

To find out more on the sponsorship and exhibition opportunities we offer for EFMC-ISMC 2012, please contact the symposium secretariat at secretariat@ISMC2012.org.